May 2
|
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
|
Apr 22
|
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
|
Apr 4
|
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
|
Mar 26
|
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 12
|
OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2023 Earnings Call Transcript
|
Mar 8
|
Q4 2023 OrthoPediatrics Corp Earnings Call
|
Mar 7
|
OrthoPediatrics Corp (KIDS) Reports Robust Revenue Growth and Improved Adjusted EBITDA in 2023
|
Mar 6
|
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Mar 6
|
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 6
|
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 4
|
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
|
Dec 7
|
OrthoPediatrics (KIDS) Introduces Unit for Non-Surgical Bracing
|
Dec 6
|
OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division
|
Dec 4
|
OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)
|
Sep 11
|
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia
|
Jul 18
|
OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023
|